Danette Dudley
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Cancer Treatment and Pharmacology, Biochemical and Molecular Research, Pharmacogenetics and Drug Metabolism, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Discovery of 2-{3-[2-(1-Isopropyl-3-methyl-1H-1,2–4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl]-1H-pyrazol-1-yl}-2-methylpropanamide (GDC-0032): A β-Sparing Phosphoinositide 3-Kinase Inhibitor with High Unbound Exposure and Robust in Vivo Antitumor Activity(2013)175 cited
- → Evaluation of new anticancer agents against the MIA PaCa-2 and PANC-1 human pancreatic carcinoma xenografts.(1993)63 cited
- → Structure-Guided Rescaffolding of Selective Antagonists of BCL-XL(2014)38 cited
- → Discovery of thiazolobenzoxepin PI3-kinase inhibitors that spare the PI3-kinase β isoform(2013)23 cited
- → Abstract DDT02-01: Discovery of GDC-0032: A beta-sparing PI3K inhibitor active against PIK3CA mutant tumors.(2013)15 cited